共 43 条
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
被引:1625
作者:
Collison, Lauren W.
Workman, Creg J.
Kuo, Timothy T.
Boyd, Kelli
Wang, Yao
Vignali, Kate M.
Cross, Richard
Sehy, David
Blumberg, Richard S.
Vignali, Dario A. A.
机构:
[1] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA
[2] St Jude Childrens Hosp, Anim Resources Ctr, Memphis, TN 38105 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[4] eBiosci, San Diego, CA 92121 USA
来源:
基金:
美国国家卫生研究院;
关键词:
D O I:
10.1038/nature06306
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Regulatory T (T-reg) cells are a critical sub-population of CD4(+) T cells that are essential for maintaining self tolerance and preventing autoimmunity(1,2), for limiting chronic inflammatory diseases, such as asthma and inflammatory bowel disease(3,4), and for regulating homeostatic lymphocyte expansion(5). However, they also suppress natural immune responses to parasites(6) and viruses(7) as well as anti-tumour immunity induced by therapeutic vaccines(8). Although the manipulation of T-reg function is an important goal of immunotherapy, the molecules that mediate their suppressive activity remain largely unknown. Here we demonstrate that Epstein-Barr-virus-induced gene 3 (Ebi3, which encodes IL-27 beta) and interleukin-12 alpha (Il12a, which encodes IL-2 alpha/p35) are highly expressed by mouse Foxp3(+) ( forkhead box P3) Treg cells but not by resting or activated effector CD4(+) T (T-eff) cells, and that an Ebi3-IL-12 alpha heterodimer is constitutively secreted by T-reg but not T-eff cells. Both Ebi3 and Il12a messenger RNA are markedly upregulated in T-reg cells co-cultured with T-eff cells, thereby boosting Ebi3 and IL-12 alpha production in trans. T-reg-cell restriction of this cytokine occurs because Ebi3 is a downstream target of Foxp3, a transcription factor that is required for T-reg-cell development and function. Ebi3(-/-) and Il12a(-/-) T-reg cells have significantly reduced regulatory activity in vitro and fail to control homeostatic proliferation and to cure inflammatory bowel disease in vivo. Because these phenotypic characteristics are distinct from those of other IL-12 family members, this novel Ebi3-IL-12 alpha heterodimeric cytokine has been designated interleukin-35 ( IL-35). Ectopic expression of IL-35 confers regulatory activity on naive T cells, whereas recombinant IL-35 suppresses T-cell proliferation. Taken together, these data identify IL-35 as a novel inhibitory cytokine that may be specifically produced by T-reg cells and is required for maximal suppressive activity.
引用
收藏
页码:566 / U19
页数:6
相关论文